December 12, 2017
The Japanese Society of Neurology has finalized the first revision of its 2017 guidelines for the treatment of Parkinson’s disease since 2011. The revised guidelines position L-dopa as the cornerstone of treatment, recommending early treatment of early-stage Parkinson’s disease starting...read more